Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?

Petros Adamidis,Despoina Pantazi,Iraklis Moschonas,Evangelos Liberopoulos,Alexandros Tselepis
DOI: https://doi.org/10.3390/jcdd11030072
2024-02-21
Journal of Cardiovascular Development and Disease
Abstract:Neutrophil extracellular traps (NETs) have attracted much attention recently, beyond elemental host immunity, due to their fundamental implication in a variety of pathologic conditions and widespread impactful diseases. Atherosclerotic cardiovascular disease (ASCVD) is one of them, and a major cause of mortality and disability worldwide. Consequently, years of basic and clinical research were dedicated to shedding light on every possible pathophysiologic mechanism that could be used as an effective prevention and treatment tool to ameliorate its burden. This led to the development of complex and prevention protocols and regimens that are now widely used, with lipid-lowering treatment being the current cornerstone; however, this is not adequate to alleviate the residual cardiovascular risk, which remains prominent. Despite the demonstrated pathogenic role of NETs in the progression and complications of ASCVD, little is known about their potential as a therapeutic target and the effects hypolipidemics exert on them.
cardiac & cardiovascular systems
What problem does this paper attempt to address?
The paper primarily explores the relationship between Neutrophil Extracellular Traps (NETs) and atherosclerosis, and investigates the impact of lipid-lowering therapy on NETs. ### Problems the paper attempts to address: 1. **The role of NETs in atherosclerosis**: - NETs are a web-like structure released by neutrophils and play a significant role in various diseases. Although NETs were initially thought to be a form of neutrophil death, recent studies have shown that they have a crucial impact on the pathological processes of diseases such as atherosclerosis. - The paper details the specific mechanisms of NETs in atherosclerosis, including how they promote inflammatory responses, cause vascular wall damage, and participate in thrombosis. 2. **The impact of lipid-lowering therapy on NETs**: - Although there are currently various lipid-lowering therapies, such as statins, ezetimibe, and PCSK9 inhibitors, the specific effects of these therapies on NETs are not yet fully understood. - The paper reviews existing literature on the impact of lipid-lowering therapy on NETs and finds conflicting conclusions from different studies. For example, some studies suggest that statins can reduce the formation of NETs, while others find that certain statins may actually increase the formation of NETs. By comprehensively analyzing these issues, the paper aims to reveal the specific mechanisms of NETs in atherosclerosis and assess whether existing lipid-lowering therapies can effectively inhibit NETs, thereby providing a theoretical basis for future clinical applications.